Human F8 / Factor VIII Antibody (Novo Nordisk patent anti-Factor VIII, Research Use)

产品名称	Human F8 / Factor VIII Antibody (Novo Nordisk patent anti-Factor VIII, Research Use)
目录号	NBR-0745
别名	DXS1253E; FVIII; FVIII; F8C; AHF
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0745-100UG	100ug	￥550	请咨询
NBR-0745-1MG	1mg	￥3500	请咨询
NBR-0745-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human F8 / Factor VIII Antibody (Novo Nordisk patent anti-Factor VIII, Research Use)
产品编号：NBR-0745
针对靶点：F8 / Factor VIII
抗体药商品名：Novo Nordisk patent anti-Factor VIII
抗体药描述：The drug is a recombinant fully human anti-Factor VIII monoclonal antibody, being developed by Novo Nordisk.

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: F8
Synonyms: DXS1253E; FVIII; FVIII; F8C; AHF
Target Description: Factor VIII, along with calcium and phospholipid, acts as a cofactor for F9/factor IXa when it converts F10/factor X to the activated form, factor Xa.
Ensembl: ENSG00000185010
Uniprot: P00451